{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T11:43:19Z","timestamp":1774698199576,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00415-020-10048-6","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T17:02:31Z","timestamp":1594918951000},"page":"3673-3682","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prodromal Parkinson disease in patients with idiopathic hyposmia"],"prefix":"10.1007","volume":"267","author":[{"given":"Paula","family":"Marrero-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Iranzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bedoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f2nica","family":"Serradell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Ni\u00f1erola-Baiz\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Perissinotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Gaig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Vilaseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isam","family":"Alobid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Santamar\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Mullol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"10048_CR1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5:525\u2013535","journal-title":"Lancet Neurol"},{"key":"10048_CR2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1212\/01.WNL.0000140706.52798.BE","volume":"63","author":"LM de Lau","year":"2004","unstructured":"de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM (2004) Incidence of parkinsonism and Parkinson disease in a general study: The Rotterdam Study. Neurology 63:1204\u20131244","journal-title":"Neurology"},{"key":"10048_CR3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Marek K, Litvan I (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131599","journal-title":"Mov Disord"},{"key":"10048_CR4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JPD-150685","volume":"5","author":"P Mahlknecht","year":"2015","unstructured":"Mahlknecht P, Seppi K, Poewe W (2015) The concept of prodromal Parkinson\u2019s disease. J Parkinsons Dis 5:681\u2013697","journal-title":"J Parkinsons Dis"},{"key":"10048_CR5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/jnnp-2015-311890","volume":"87","author":"AJ Noyce","year":"2016","unstructured":"Noyce AJ, Lees AJ, Schrag AE (2016) The prediagnostic phase of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 87:871\u2013878","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10048_CR6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","volume":"12","author":"RB Postuma","year":"2016","unstructured":"Postuma RB, Berg D (2016) Advances in markers of prodromal Parkinson disease. Nat Rev Neurol 12:622\u2013634","journal-title":"Nat Rev Neurol"},{"key":"10048_CR7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1212\/WNL.33.7.943","volume":"33","author":"CD Ward","year":"1983","unstructured":"Ward CD, Hess WA, Calne DB (1983) Olfactory impairment in Parkinson\u2019s disease. Neurology 33:943\u2013946","journal-title":"Neurology"},{"key":"10048_CR8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/mds.10379","volume":"18","author":"C Hawkes","year":"2003","unstructured":"Hawkes C (2003) Olfaction in neurodegenerative disorder. Mov Disord 18:364\u2013372","journal-title":"Mov Disord"},{"key":"10048_CR9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1531-8257(200101)16:1<41::AID-MDS1017>3.0.CO;2-M","volume":"16","author":"G Tissingh","year":"2011","unstructured":"Tissingh G, Berendese HW, Bergmans P et al (2011) Loss of olfaction in de novo and treated Parkinson\u2019s disease: possible implications for early diagnosis. Mov Disord 16:41\u201346","journal-title":"Mov Disord"},{"key":"10048_CR10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mds.26077","volume":"30","author":"C Pont-Sunyer","year":"2015","unstructured":"Pont-Sunyer C, Hotter A, Gaig C et al (2015) The onset of nonmotor symptoms in Parkinson\u2019s disease (The ONSET PD Study). Mov Disord Mov Disord 30:229\u2013237","journal-title":"Mov Disord Mov Disord"},{"issue":"8","key":"10048_CR11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11882-018-0796-4","volume":"18","author":"C Marin","year":"2018","unstructured":"Marin C, Vilas D, Langdon C et al (2018) Olfactory dysfunction in neurodegenerative diseases. Curr Allergy Asthma Rep 18(8):42","journal-title":"Curr Allergy Asthma Rep"},{"key":"10048_CR12","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-201972","author":"D Vilas","year":"2020","unstructured":"Vilas D, Tolosa E, Quintana M et al (2020) Olfaction in LRRK2 linked Parkinson\u2019s disease: is it different from idiopathic Parkinson\u2019s disease? J Parkinsons Dis.\u00a0https:\/\/doi.org\/10.3233\/JPD-201972","journal-title":"J Parkinsons Dis"},{"key":"10048_CR13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/mds.21413","volume":"22","author":"A Haehner","year":"2007","unstructured":"Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H (2007) Olfactory loss may be a first sign of idiopathic Parkinson\u2019s disease. Mov Disord 22:839\u2013842","journal-title":"Mov Disord"},{"key":"10048_CR14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ana.21291","volume":"67","author":"GW Ross","year":"2008","unstructured":"Ross GW, Petrovitch H, Abbott RD et al (2008) Association of olfactory dysfunction with risk for future Parkinson\u2019s disease. Ann Neurol 67:167\u2013173","journal-title":"Ann Neurol"},{"key":"10048_CR15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/jamaneurol.2017.0985","volume":"74","author":"D Jennings","year":"2017","unstructured":"Jennings D, Siderowf A, Stern M et al (2017) Conversion to Parkinson disease in the PARS hyposmic and dopamine transporter-deficit prodromal cohort. JAMA Neurol 74:933\u2013940","journal-title":"JAMA Neurol"},{"key":"10048_CR16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mds.26898","volume":"32","author":"AJ Noyce","year":"2017","unstructured":"Noyce AJ, R\u2019Bibo L, Peress L et al (2017) PREDICT-PD: an online approach to prospectively identify risk indicators of Parkinson\u2019s disease. Mov Disord 32:219\u2013226","journal-title":"Mov Disord"},{"key":"10048_CR17","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/ana.22282","volume":"69","author":"RB Postuma","year":"2011","unstructured":"Postuma RB, Gagnon J-F, Vendette M, Desjardins C, Montplaisir JY (2011) Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 69:811\u2013818","journal-title":"Ann Neurol"},{"key":"10048_CR18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1212\/WNL.0000000000001265","volume":"84","author":"P Mahlknecht","year":"2015","unstructured":"Mahlknecht P, Iranzo A, H\u00f6gl B et al (2015) Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD. Neurology 84:654\u2013658","journal-title":"Neurology"},{"key":"10048_CR19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ana.20160","volume":"56","author":"MM Ponsen","year":"2004","unstructured":"Ponsen MM, Stoffers D, Booji J, van Eck-Smit BLF, Wolters E, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson\u2019s disease. Ann Neurol 56:173\u2013181","journal-title":"Ann Neurol"},{"key":"10048_CR20","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1001\/jama.288.18.2307","volume":"288","author":"C Murphy","year":"2002","unstructured":"Murphy C, Schubert CR, Cruickshanks KJ, Klein BEK, Klein R, Nondhal DM (2002) Prevalence of olfactory impairment in older adults. JAMA 288:2307\u20132312","journal-title":"JAMA"},{"key":"10048_CR21","doi-asserted-by":"crossref","first-page":"e001256","DOI":"10.1136\/bmjopen-2012-001256","volume":"2","author":"J Mullol","year":"2012","unstructured":"Mullol J, Alobid I, Mari\u00f1o-S\u00e1nchez F et al (2012) Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study). BMJ Open 2:e001256","journal-title":"BMJ Open"},{"key":"10048_CR22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/mds.24892","volume":"27","author":"A Siderowf","year":"2012","unstructured":"Siderowf A, Jennings D, Eberly S et al (2012) Impaired olfaction and other prodromal features in the parkinson at-risk syndrome study. Mov Disord 27:406\u2013412","journal-title":"Mov Disord"},{"key":"10048_CR23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00415-018-9135-x","volume":"266","author":"A Haehner","year":"2019","unstructured":"Haehner A, Masala C, Walter S, Reichmann H, Hummel T (2019) Incidence of Parkinson\u2019s disease in a large patient cohort with idiopathic smell and taste loss. J Neurol 266:339\u2013345","journal-title":"J Neurol"},{"key":"10048_CR24","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH et al (2015) MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 30:1600\u20131609","journal-title":"Mov Disord"},{"key":"10048_CR25","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/mds.27802","volume":"34","author":"S Heinzel","year":"2019","unstructured":"Heinzel S, Berg D, Gasser T et al (2019) Update of the MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 34:1464\u20131470","journal-title":"Mov Disord"},{"key":"10048_CR26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/mds.27281","volume":"33","author":"P Mahlknecht","year":"2018","unstructured":"Mahlknecht P, Gasperi A, Djamshidian A et al (2018) Performance of the Movement Disorders Society criteria for prodromal Parkinson\u2019s disease: a population-based 10-year study. Mov Disord 33:405\u2013413","journal-title":"Mov Disord"},{"key":"10048_CR27","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/mds.27035","volume":"32","author":"A Pilotto","year":"2017","unstructured":"Pilotto A, Heinzel S, Suenkel U et al (2017) Application of the movement disorder society prodromal Parkinson\u2019s disease research criteria in 2 independent prospective cohorts. Mov Disord 32:1025\u20131034","journal-title":"Mov Disord"},{"key":"10048_CR28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1212\/WNL.0000000000004121","volume":"89","author":"A Iranzo","year":"2017","unstructured":"Iranzo A, Stefani A, Serradell M et al (2017) Characterization of patients with longstanding idiopathic REM sleep behavior disorder. Neurology 89:242\u2013248","journal-title":"Neurology"},{"key":"10048_CR29","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/mds.26989","volume":"32","author":"SM Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad SM, Montplaisir JY, Pelletier A, Gagnon JF, Berg D, Postuma RB (2017) Validation of the MDS research criteria for prodromal Parkinson\u2019s disease: longitudinal assessment in a REM sleep behavior disorder (RBD) cohort. Mov Disord 32:865\u2013873","journal-title":"Mov Disord"},{"key":"10048_CR30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3233\/JPD-161036","volume":"7","author":"M Skorvanek","year":"2017","unstructured":"Skorvanek M, Ladomirjakova Z, Han V et al (2017) Prevalence of prodromal Parkinson\u2019s disease as defined by MDS research criteria among elderly patients undergoing colonoscopy. J Parkinsons Dis 7:481\u2013489","journal-title":"J Parkinsons Dis"},{"key":"10048_CR31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/mds.27342","volume":"33","author":"A Mirelman","year":"2018","unstructured":"Mirelman A, Saunders-Pullman R, Alcalay RN et al (2018) Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers. Mov Disord 33:966\u2013973","journal-title":"Mov Disord"},{"key":"10048_CR32","first-page":"83","volume":"44","author":"A Cardesin","year":"2006","unstructured":"Cardesin A, Alobid I, Benitez P et al (2006) Barcelona Smell Test-24 (BAST-24): validation and smell characteristics in the healthy Spanish population. Rhinology 44:83\u201389","journal-title":"Rhinology"},{"key":"10048_CR33","volume-title":"International classification of sleep disorders","author":"American Academy of Sleep Medicine","year":"2014","unstructured":"American Academy of Sleep Medicine (2014) International classification of sleep disorders, 3rd edn. American Academy of Sleep Medicine, Darien","edition":"3"},{"key":"10048_CR34","doi-asserted-by":"crossref","first-page":"835","DOI":"10.5665\/sleep.1886","volume":"35","author":"B Frauscher","year":"2012","unstructured":"Frauscher B, Iranzo A, Gaig C et al (2012) Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder. Sleep 35:835\u2013847","journal-title":"Sleep"},{"key":"10048_CR35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ana.25026","volume":"82","author":"A Iranzo","year":"2017","unstructured":"Iranzo A, Santamar\u00eda J, Valldeoriola F et al (2017) Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder. Ann Neurol 82:419\u2013428","journal-title":"Ann Neurol"},{"key":"10048_CR36","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129\u20132170","journal-title":"Mov Disord"},{"key":"10048_CR37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","volume":"21","author":"R Freeman","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB et al (2011) Consensus statement on the definition of orthostatic hypotension, neutrally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21:69\u201372","journal-title":"Clin Auton Res"},{"key":"10048_CR38","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","volume":"130","author":"GF Longstreth","year":"2006","unstructured":"Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006) Functional bowel disorders. Gastroenterology 130:1480\u20131491","journal-title":"Gastroenterology"},{"key":"10048_CR39","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540\u2013545","journal-title":"Sleep"},{"key":"10048_CR40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, Bedirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695\u2013699","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"10048_CR41","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.nrl.2017.01.013","volume":"34","author":"C Delgado","year":"2019","unstructured":"Delgado C, Araneda A, Behrens MI (2019) Validation of the Spanish-language version of the Montreal Cognitive Assessment test in adults older than 60 years. Neurologia 34(6):376\u2013385","journal-title":"Neurologia"},{"key":"10048_CR42","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013)\u00a0Diagnostic and statistical manual of mental disorders,\u00a05th edn. Arlington, Washington","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10048_CR43","volume-title":"The smell identification test administration manual","author":"RL Doty","year":"1995","unstructured":"Doty RL (1995) The smell identification test administration manual, 3rd edn. Sensonics, Philadelphia","edition":"3"},{"key":"10048_CR44","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/mds.26674","volume":"31","author":"P Mahlknecht","year":"2016","unstructured":"Mahlknecht P, Gasperi A, Willeit P et al (2016) Prodromal Parkinson\u2019s disease as defined per MDS research criteria in the general elderly community. Mov Disord 31:1405\u20131408","journal-title":"Mov Disord"},{"key":"10048_CR45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1474-4422(16)00057-0","volume":"15","author":"A Iranzo","year":"2016","unstructured":"Iranzo A, Santamaria J, Tolosa E (2016) Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions. Lancet Neurol 15:405\u2013419","journal-title":"Lancet Neurol"},{"key":"10048_CR46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.sleep.2017.07.021","volume":"40","author":"M Pujol","year":"2017","unstructured":"Pujol M, Pujol J, Alonso T et al (2017) Idiopathic REM sleep behavior disorder in the elderly Spanish community: a primary care center study with a two-stage design using video-polysomnography. Sleep Med 40:116\u2013121","journal-title":"Sleep Med"},{"issue":"2","key":"10048_CR47","doi-asserted-by":"crossref","first-page":"e89741","DOI":"10.1371\/journal.pone.0089741","volume":"9","author":"A Iranzo","year":"2014","unstructured":"Iranzo A, Fern\u00e1ndez-Arcos A, Tolosa E et al (2014) Neurodegenerative disorder risk in Idiopathic REM sleep behavior disorder: study in 174 patients. PLoS One 9(2):e89741","journal-title":"PLoS One"},{"key":"10048_CR48","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/brain\/awz014","volume":"142","author":"RS Weil","year":"2019","unstructured":"Weil RS, Morris HR (2019) REM sleep behaviour disorder: an early window for prevention in neurodegeneration? Brain 142:498\u2013501","journal-title":"Brain"},{"key":"10048_CR49","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.brainresbull.2006.07.008","volume":"70","author":"ML Fantini","year":"2006","unstructured":"Fantini ML, Postuma RB, Montplaisir J, Ferini-Strambi L (2006) Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder. Brain Res Bull 70:386\u2013390","journal-title":"Brain Res Bull"},{"key":"10048_CR50","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.parkreldis.2013.02.009","volume":"19","author":"A Iranzo","year":"2013","unstructured":"Iranzo A, Serradell M, Vilaseca I et al (2013) Longitudinal assessment of olfactory function in idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord 19:600\u2013604","journal-title":"Parkinsonism Relat Disord"},{"key":"10048_CR51","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/WNL.0000000000000960","volume":"83","author":"D Jennings","year":"2014","unstructured":"Jennings D, Siderowf A, Stern M et al (2014) Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study. Neurology 83:1739\u20131746","journal-title":"Neurology"},{"key":"10048_CR52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00006231-200505000-00005","volume":"26","author":"L Filippi","year":"2005","unstructured":"Filippi L, Manni C, Pierantozzi M et al (2005) 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson\u2019s disease with unilateral symptoms. Nucl Med Commun 26:421\u2013426","journal-title":"Nucl Med Commun"},{"key":"10048_CR53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jnnp.62.2.133","volume":"62","author":"J Booji","year":"1997","unstructured":"Booji J, Tissingh G, Boer GJ et al (1997) [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 62:133\u2013140","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10048_CR54","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ (1991) Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain 114:2283\u20132301","journal-title":"Brain"},{"key":"10048_CR55","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","volume":"15","author":"HTS Benamer","year":"2000","unstructured":"Benamer HTS, Patterson J, Wyper DJ, Hadley DM, Macphee GJ, Grosset DG (2000) Correlation of Parkinson\u2019s disease severity and duration with [123I]-FP-CIT SPECT striatal uptake. Mov Disord 15:692\u2013698","journal-title":"Mov Disord"},{"key":"10048_CR56","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(11)70152-1","volume":"10","author":"A Iranzo","year":"2011","unstructured":"Iranzo A, Valldeoriola F, Lome\u00f1a F et al (2011) Progressive nigrostriatal dopaminergic dysfunction in idiopathic REM sleep behavior disorder: a prospective study. Lancet Neurol 10:797\u2013805","journal-title":"Lancet Neurol"},{"key":"10048_CR57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/jnnp-2012-303419","volume":"84","author":"R Erro","year":"2013","unstructured":"Erro R, Picillo M, Vitale C et al (2013) Non-motor symptoms in early Parkinson\u2019s disease: a 2-year follow-up study on previously untreated patients. J Neurol Neurosurg Psychiatry 84:14\u201317","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10048_CR58","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0b013e31827deb74","volume":"80","author":"TK Khoo","year":"2013","unstructured":"Khoo TK, Yarnall AJ, Duncan GW et al (2013) The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 80:276\u2013281","journal-title":"Neurology"},{"key":"10048_CR59","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","volume":"24","author":"P Barone","year":"2009","unstructured":"Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease. Mov Disord 24:1641\u20131649","journal-title":"Mov Disord"},{"key":"10048_CR60","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/mds.23499","volume":"26","author":"A Gaenslen","year":"2011","unstructured":"Gaenslen A, Swid I, Liepelt-Scarfone I, Godau J, Berg D (2011) The patients\u2019 perception of prodromal symptoms before the initial diagnosis of Parkinson\u2019s disease. Mov Disord 26:653\u2013658","journal-title":"Mov Disord"},{"key":"10048_CR61","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","volume":"14","author":"A Schrag","year":"2015","unstructured":"Schrag A, Horsfall L, Walters K, Noyce A, Petersen I (2015) Prediagnostic presentations of Parkinson\u2019s disease in primary care: a case-control study. Lancet Neurol 14:57\u201364","journal-title":"Lancet Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10048-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10048-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10048-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T23:53:05Z","timestamp":1626393185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10048-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10048"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10048-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"17 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors had no financial disclosures and no conflict of interests concerning the research related to the current study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This human study has been approved by our local ethics committee and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"The study was approved by the local ethics committee of our institution and written informed consent was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}